Breast Cancer Imaging Using the Near-Infrared Fluorescent Agent, CLR1502

Breast Cancer Imaging Using the Near-Infrared Fluorescent Agent, CLR1502

Positive margins after breast conservation surgery represent a significant problem in the treatment of breast cancer. The near-infrared fluorescence agent CLR1502 (Cellectar Biosciences, Madison, WI) was studied in a preclinical breast cancer model to determine imaging properties and ability to dete...

Full description

Saved in:
Bibliographic Details
Main Authors: Melissa L. Korb, Jason M. Warram, Joseph Grudzinski, Jamey Weichert, Justin Jeffery, Eben L. Rosenthal
Format: Article
Language:English
Published: SAGE Publishing 2015-01-01
Series:Molecular Imaging
Online Access:https://doi.org/10.2310/7290.2014.00040
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items